-
Jan 10, 2025 | 
jamanetwork.com | Avery Orrall |Howard Larkin
Using the American Heart Association’s recently formulated equation for Predicting Risk of Cardiovascular Disease EVENTs (PREVENT), a new study measured the population-wide threat of heart failure (HF) and estimated that 15 million US adults have an elevated risk.
-
Aug 16, 2024 | 
jamanetwork.com | Samantha Anderer |Howard Larkin
New Cardiovascular Risk Calculator Could Reduce Blood Pressure Medication Prescribing Medical News & Perspectives After a Decade, Goodbye to the Pooled Cohort Equations? News From the JAMA Network How Statin Eligibility Could Change With the New CVD Risk Calculator Statin and Antihypertensive Therapy Eligibility With the PREVENT Cardiovascular Risk Equations James A. Diao, MD, MPhil; Ivy Shi, MD; Venkatesh L. Murthy, MD, PhD; Thomas A. Buckley, BS; Chirag J.
-
Jun 21, 2024 | 
jamanetwork.com | Howard Larkin
Roughly 45 million people in the US take statins, the cholesterol-lowering medications used to prevent cardiovascular disease. Many patients without heart disease, though, are taking them based on older estimates of their risk of developing it. Now, research suggests that millions of them may no longer qualify for statins because of a newer prediction model that estimates the 10-year risk of atherosclerotic cardiovascular disease (ASCVD).
-
Feb 21, 2024 | 
jamanetwork.com | Emily Harris |Howard Larkin
Researchers have begun studying how accurately a new tool, known as the Predicting Risk of Cardiovascular Disease Events (PREVENT) calculator, estimates risk in people from different racial and ethnic backgrounds as well as from a range of ages, the American Heart Association announced. Three research teams will evaluate the new scores using larger databases and will assess PREVENT’s fairness and cost-effectiveness compared with the Pooled Cohort Equations (PCEs).
-
Dec 27, 2023 | 
jamanetwork.com | Howard Larkin
After 10 years, the American Heart Association (AHA) has updated its cardiovascular disease risk calculator for all adults aged 30 to 79 years without known cardiovascular disease. The Predicting Risk of Cardiovascular Disease Events (PREVENT) calculator is based on newer data from a larger, more diverse sample than the existing tool, the commonly used Pooled Cohort Equations (PCEs), released in 2013 for non-Black Hispanic and White adults aged 40 to 79 years.
-
Nov 8, 2023 | 
jamanetwork.com | Howard Larkin
Cardiovascular disease often occurs with kidney disease and metabolic diseases, including obesity and type 2 diabetes. And having more than 1 of these conditions multiplies health and mortality risks, particularly due to cardiovascular disease. An American Heart Association (AHA) presidential advisory recently published in Circulation newly defines the adverse interplay among these conditions as cardiovascular-kidney-metabolic (CKM) syndrome.
-
May 31, 2023 | 
escrs.org | Howard Larkin
By Howard LarkinWhether running a private or public clinic, conducting medical research, or developing new technologies, building a successful ophthalmology practice requires mastering skills beyond those taught in medical school. Juggling multiple management roles in a rapidly changing environment is the focus of this year’s Leadership and Business Innovation Programme Masterclass at the 41st Congress of the ESCRS in Vienna.
-
Apr 30, 2023 | 
escrs.org | Howard Larkin
Team building and business skills help make a successful department.
By Howard LarkinKeeping up with rapidly advancing patient needs, technology, and evolving public-private medical service delivery partnerships can be a challenge for public ophthalmology departments. Cultivating team building and business skills is essential for success, said presenters in the Leadership and Business Innovation Programme at the 40th Congress of the ESCRS in Milan.
-
Feb 1, 2023 | 
jamanetwork.com | Howard Larkin
A recent systematic review of studies found that people who have been vaccinated against COVID-19 and have had a previous SARS-CoV-2 infection, known as having hybrid immunity, have better protection against the Omicron variant than those with only a previous infection.
The effectiveness of hybrid immunity against hospital admission or severe disease was 97% at 12 months compared with 75% after infection alone.
-
Feb 1, 2023 | 
jamanetwork.com | Howard Larkin
Patients with sepsis-induced hypotension resuscitated in the first 24 hours with lower volumes of intravenous fluid and greater vasopressor use were about as likely to survive as patients treated with higher intravenous fluid volumes prioritized over vasopressors. The trial results, reported in the New England Journal of Medicine, contradicted the initial hypothesis that a restricted fluid strategy would reduce mortality.
